• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Transcutaneous pO2 and laser Doppler flux in increasing doses of intraarterial and intravenously administered prostaglandin E1].

作者信息

Creutzig A, Caspary L, Ranke C, Kiessling D, Wilkens J, Frölich J, Alexander K

出版信息

Vasa. 1987;16(2):114-8.

PMID:2955602
Abstract
摘要

相似文献

1
[Transcutaneous pO2 and laser Doppler flux in increasing doses of intraarterial and intravenously administered prostaglandin E1].[经皮氧分压和激光多普勒血流在递增剂量动脉内和静脉内给予前列腺素E1时的变化]
Vasa. 1987;16(2):114-8.
2
Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates.接受动脉内输注前列腺素E1或核苷酸磷酸盐的动脉闭塞性疾病患者的经皮氧分压和激光多普勒血流仪检测
Prog Clin Biol Res. 1987;242:433-8.
3
[Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].[严重动脉闭塞性疾病患者静脉输注前列腺素E1期间经皮氧分压（tcPO2）行为的双盲安慰剂对照研究]
Vasa Suppl. 1992;35:36-8.
4
Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.对患有外周动脉闭塞性疾病的患者，动脉内和静脉内给予前列腺素E1会引起皮肤微循环的不同变化。
Vasa. 1998 May;27(2):100-5.
5
[Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
Srp Arh Celok Lek. 1992 Jan-Feb;120(1-2):9-14.
6
Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
Angiology. 1995 May;46(5):357-67. doi: 10.1177/000331979504600501.
7
Intraarterial perfusion of prostaglandin E1 after lumbar sympathectomy or reconstruction on femoropopliteal segment.
Int Angiol. 1991 Jul-Sep;10(3):178-81.
8
[Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].[静脉注射前列腺素E1治疗II b期动脉闭塞性疾病的经验]
Vasa Suppl. 1990;30:139-41.
9
[Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Vasa Suppl. 1988;23:121-5.
10
[Prostaglandin E1 in intermittent claudication].[前列腺素E1与间歇性跛行]
Vasa Suppl. 1992;35:147-8.

引用本文的文献

1
Cardiac and microcirculatory effects of different doses of prostaglandin E1 in man.
Eur J Clin Pharmacol. 1987;33(2):133-7. doi: 10.1007/BF00544556.
2
Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.动脉闭塞性疾病患者应用前列腺素E1期间的皮肤表面氧压场
Klin Wochenschr. 1990 Feb 15;68(4):207-12. doi: 10.1007/BF01662716.
3
Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation.
Eur J Clin Pharmacol. 1991;41(2):131-6. doi: 10.1007/BF00265905.